BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹517 Cr | ₹439 Cr | ₹404 Cr | ₹385 Cr | ₹393 Cr |
What is the latest Sundry Debtors ratio of BLISS GVS PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹517 Cr |
| Mar2025 | ₹439 Cr |
| Mar2024 | ₹404 Cr |
| Mar2023 | ₹385 Cr |
| Mar2022 | ₹393 Cr |
How is Sundry Debtors of BLISS GVS PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹517 Cr | 17.86 | |
| Mar2025 | ₹439 Cr | 8.52 | |
| Mar2024 | ₹404 Cr | 4.98 | |
| Mar2023 | ₹385 Cr | -1.93 | |
| Mar2022 | ₹393 Cr | - | |
Compare Sundry Debtors of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹7,840.7 Cr | 6.8% | 31.9% | 368.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 6.8% |
31.9% |
368.5% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses